Omnia Wellness (OMWS) 10-K 17 Oct 22 2022 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Mar. 31, 2022	Jul. 14, 2022	Jun. 30, 2021
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2022
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--03-31
Entity File Number	333-211986
Entity Registrant Name	Omnia Wellness Inc.
Entity Central Index Key	0001676852
Entity Tax Identification Number	98-1291924
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	999 18th Street
Entity Address, Address Line Two	Suite 3000
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
City Area Code	(303)
Local Phone Number	325-3738
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	OMWS
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 7,948,685
Entity Common Stock, Shares Outstanding		232,222,818
Documents Incorporated by Reference [Text Block]	Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
Auditor Firm ID	5041
Auditor Name	BF Borgers CPA PC
Auditor Location	Lakewood, CO

Consolidated Balance Sheet

Consolidated Balance Sheet - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Current assets:
Cash	$ 1,894	$ 28,761
Accounts receivable	206,949	38,341
Due from related parties	2,780	163,200
Advances on inventory		16,000
Inventory	24,000
Total current assets	235,623	246,302
Non-current assets:
Fixed assets, net	515,113	314,377
Intangible assets, net	1,450,900	1,600,975
ROU assets, net	160,197
Total non-current assets	2,126,210	1,915,352
Total assets	2,361,832	2,161,654
Current liabilities:
Accounts payable and accrued liabilities	562,213	103,205
Accounts payable, related party		1,500
Deposit liability	8,002	21,764
Accrued interest	615,261	427,910
Lease liability	99,464
Warranty liability	25,667	25,667
Royalty Liability	143,817	0
Nonconvertible notes, related party	1,102,735	834,653
Nonconvertible notes	1,765,219	1,745,000
Convertible notes, related party	29,970	29,970
Convertible notes	1,229,443	1,107,143
Total current liabilities	5,581,790	4,296,812
Non-current liabilities:
Advances due to related party	143,239
Lease liability	80,099
PPP Loan		588,891
Senior secured notes	675,000
Nonconvertible notes, related party	891,920	509,972
Nonconvertible notes	189,918	174,620
Total non-current liabilities	1,980,176	1,273,483
Total liabilities	7,561,966	5,570,294
Stockholders’ deficit:
Stock Payable	642,867
Preferred stock; 150,000,000 shares authorized; no shares issued or outstanding
Common stock; $0.001 par value, 1,500,000,000 shares authorized; 232,222,818 and 224,227,107 issued and outstanding, respectively	232,223	14,900
Common stock subscribed: $0.001 par value subscribed common shares, 2,500,000 and -0- shares outstanding, respectively	2,500
Additional paid-in capital	5,344,318	2,065,923
Accumulated deficit	(11,012,042)	(5,489,464)
Subscription Receivable	(410,000)
Total stockholders’ deficit	(5,200,134)	(3,408,640)
Total liabilities and stockholders’ deficit	$ 2,361,832	$ 2,161,654

Consolidated Balance Sheet (Par

Consolidated Balance Sheet (Parenthetical) - $ / shares	Mar. 31, 2022	Mar. 31, 2021
Statement of Financial Position [Abstract]
Preferred Stock, Shares Authorized	150,000,000	150,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	1,500,000,000	1,500,000,000
Common Stock, Shares, Issued	232,222,818	224,227,107
Common Stock, Shares, Outstanding	232,222,818	224,227,107
Common stock subscribed, par value	$ 0.001	$ 0.001
Common stock subscribed, shares outstanding	2,500,000	0

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue
Total revenue	$ 290,715	$ 218,874
Cost of goods sold
Cost of goods sold	77,327	120,253
Total cost of goods sold	77,327	120,253
Gross Profit	213,388	98,621
Operating expenses:
Warranty expense		13,399
Depreciation and amortization	322,317	272,779
Legal and professional fees	321,092	177,589
Payroll expense	335,509	240,395
Selling and marketing expense	62,996	52,804
Selling and marketing expense, related party	87	356,261
Consulting	1,020,154	25,985
Consulting, related party	13,620	244,186
License royalties		33,771
General and administrative	370,139	304,992
Research and development	1,019,200
Total operating expenses	3,608,929	1,722,161
Other (income) expense:
Gain on PPP loan forgiven	(593,546)
Loss on debt settlement	30,713
Interest expense and finance costs	2,689,870	611,536
Total other (income) expense	2,127,037	611,536
Net loss	$ (5,522,578)	$ (2,235,075)
Net loss per common share – basic and diluted	$ (0.02)	$ (0.01)
Weighted average common shares outstanding-basic and diluted	227,242,753	191,762,740
Sales, Net [Member]
Revenue
Total revenue	$ 286,284	$ 218,124
Lease Income [Member]
Revenue
Total revenue	2,694
Freight and Delivery Income [Member]
Revenue
Total revenue	$ 1,737	$ 750

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' (Deficit) - USD ($)	Common Stock [Member]	Common Stock Receivable [Member]	Preferred Stock Shares [Member]	Preferred Stock [Member]	Stock payable [Member]	Subscription Receivable [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Mar. 31, 2020	$ 55,058						$ (10,224)	$ (77,847)	$ (33,013)
Shares, Outstanding, Beginning Balance at Mar. 31, 2020	264,384,488
Change in shares issued	$ (40,158)								(40,158)
Stock Issued During Period, Shares, Period Increase (Decrease)	(40,157,381)
Conversion of debt							2,076,147		2,076,147
Reverse merger, consolidation adjustment								(3,176,541)	(3,176,541)
Net loss								(2,235,075)	(2,235,075)
Ending balance, value at Mar. 31, 2021	$ 14,900						2,065,923	(5,489,464)	(3,408,640)
Shares, Outstanding, Ending Balance at Mar. 31, 2021	224,227,107
Net loss								(5,522,578)	(5,522,578)
Reclass par value of shares	209,327						(209,327)
Beneficial conversion feature on convertible notes							914,075		914,075
Subscription Receivable						(410,000)			(410,000)
Common Stock Recievable		2,500					(2,500)
Stock issued for conversion of debt	$ 4,626				150,867		819,757		975,250
Stock Issued During Period, Shares, Conversion of Convertible Securities	4,626,339
Stock issued for note extensions	$ 1,600				15,000		670,400		687,000
[custom:StockIssuedDuringPeriodSharesNoteExtension]	1,600,000
Stock issued for consulting	$ 1,315				64,500		418,785		484,600
Stock Issued During Period, Shares, Issued for Services	1,314,827
Stock issued at $0.16					287,500				287,500
Stock issued at $0.17					125,000				125,000
Stock issued at $0.22	$ 455						99,545		100,000
[custom:StockIssuedDuringPeriodSharesNewIssuesTwo]	454,545
Warrants issued							567,660		567,660
Ending balance, value at Mar. 31, 2022	$ 232,223	$ 2,500			$ 642,867	$ (410,000)	$ 5,344,318	$ (11,012,042)	$ (5,200,134)
Shares, Outstanding, Ending Balance at Mar. 31, 2022	232,222,818

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Stockholders' (Deficit) (Parenthetical)	Mar. 31, 2022 $ / shares
Stock Issued One [Member]
Shares Issued, Price Per Share	$ 0.16
Stock Issued Two [Member]
Shares Issued, Price Per Share	0.17
Stock Issued Three [Member]
Shares Issued, Price Per Share	$ 0.22

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (5,522,578)	$ (2,235,075)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	218,590	272,779
BCF on convertible notes	914,076
Loss on debt settlement	30,713
Stock based compensation	484,600
Amortization of ROU asset	104,266
Amortization of warrants	567,660
Discount on notes	25,000
Finance costs related to note payable	216,506
Finance costs paid in stock	672,000
Gain on PPP loan forgiven	(593,546)
Rent payments on lease liability	(84,899)
Bad debt expense	(2,200)
Change in:
Accounts receivables, net	(168,608)	(38,341)
Due from related parties	160,420	(163,200)
Inventory	(24,000)
Deposits	(13,762)
Advance payments on purchase of inventory, related party	16,000	(16,000)
Accounts payable and accrued liabilities	427,508	152,136
Interest payable	261,755	413,443
Net cash used - operating activities	(2,166,683)	(1,614,258)
Cash flows from investing activities:
Purchase of fixed assets	(269,251)	(387,131)
Payments on license agreement, related party		(1,801,000)
Net cash used – investing activities	(269,251)	(2,188,131)
Cash flows from financing activities:
Subscriptions receivable	(410,000)
Proceeds from advances	606,158
Proceeds from loans payable	2,860,000	4,971,703
Payments on loans payable	(684,672)
Payments on advances	(432,920)
Increase in stock subscription payable	370,500
Proceeds from issuing stock net of offering costs	100,000
Change in shareholders’ equity, net		(1,100,394)
Change in common stock		(40,158)
Net cash provided - financing activities	2,409,066	3,831,151
Net increase (decrease) in cash	(26,867)	28,761
Cash - beginning of year	28,761
Cash - end of year	1,894	$ 28,761
Non-cash investing and financing activities:
Issuance of common stock for notes payable	905,500
Issuance of common stock for interest payable	$ 69,750

NATURE OF OPERATIONS

NATURE OF OPERATIONS	12 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS	1. NATURE OF OPERATIONS Omnia Wellness Inc. (the “Company”) was incorporated as a Nevada corporation on March 2, 2016 Nevada On June 25, 2019, Maksim Charniak, the Company’s then sole executive officer and director and the owner of 3,000,000 95.6% On March 5, 2020, the Company filed Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada to, among other things, (i) increase the Company’s authorized shares of common stock from 75,000,000 100,000,000 10,000,000 12.6374:1 On April 17, 2020, the Company entered into a Share Exchange and Reorganization Agreement (the “Exchange Agreement”) with Omnia Wellness Corporation (formerly known as Bed Therapies Inc.), a Texas corporation (“Omnia Corp.”), and the beneficial stockholders of Omnia Corp. to acquire 100% 0.001 Accordingly, the Company acquired 100% of Omnia Corp. in exchange for the issuance of 10,000,000 (not adjusted to reflect the Company’s 15:1 forward stock split on April 6, 2021) shares of the Company’s common stock and Omnia Corp. became the Company’s wholly-owned subsidiary. As of the closing of the Acquisition (the “Closing”), Mr. Samad, resigned as an officer and director of the Company and agreed to cancel 52,656,888 1,269,665 539,000 As of immediately prior to the closing of the Acquisition, the Company entered into an Assignment and Assumption Agreement with RZI Consulting LLC (the “Assignment Agreement”), pursuant to which RZI Consulting LLC assumed substantially all of the Company’s remaining assets and liabilities through the closing of the Acquisition. Accordingly, as of the closing of the Acquisition, the Company had no assets or liabilities (other than relating to general and administrative expenses). Following the Acquisition, the Company, through its wholly-owned subsidiary Omnia Corp., now develops and markets products for wellness and physical therapy markets, using patented dry-hydro therapy equipment that the Company plans to offer and sell in medical and fitness markets. On April 6, 2021, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to (i) increase the Company’s authorized shares of common stock from 100,000,000 1,500,000,000 10,000,000 150,000,000 The Company’s principal executive office is located at 999 18 th In March 2020 the World Health Organization declared COVID-19 a pandemic. The Company is still assessing the impact COVID-19 may have on its business, but there can be no assurance that this analysis will enable the Company to avoid part or all of any impact from the spread of COVID-19 or its consequences, including downturns in business sentiment generally. The extent to which the COVID-19 pandemic and global efforts to contain its spread will impact the Company’s operations will depend on future developments, which are highly uncertain and cannot be predicted at this time, and include the duration, severity and scope of the pandemic and the actions taken to contain or treat the COVID-19 pandemic.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The principal accounting policies applied in the preparation of these financial statements are set out below. Basis of Presentation Principles of Consolidation Accounting Estimates Risks and Uncertainties Loss Per Common Share 227,242,753 191,762,740 Cash Accounts Receivable 206,949 38,341 Other Receivable 410,000 410,000 0 Related Party Transactions Advance Payments on Purchases of Inventory, related party 0 16,000 Fixed Assets 194,219 108,746 Patent Cost 10 550,100 362,500 Leases License Payable, related party Warranty Liability Beneficial Conversion Features Derivatives Revenue The Company derives its revenues primarily from the usage fees and sales of hydrotherapy massage beds and installation services. Revenues from sales are recognized when the products are sold and delivered to its customers and the usage fees are earned based on subscription or actual usage. Sales taxes and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Shipping and handling fees charged to customers are reported within revenue. Income Taxes The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary. Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary. Fair Value of Financial Instruments Fair Value Measurements and Disclosures ● Level 1: Quoted prices for identical assets and liabilities in active markets; ● Level 2: Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and ● Level 3: Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amounts of financial instruments including cash, accounts payable, warrant liability and notes payable approximated fair value as of March 31, 2022 and 2021 due to the relatively short maturity of the respective instruments. Recently Issued Accounting Pronouncements – Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments In August 2020, the FASB issued ASU 2020-06 , Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Derivatives and Hedging Derivatives and Hedging—Contracts in Entity’s Own Equity As of March 31, 2022, there were several new accounting pronouncements issued by the Financial Accounting Standards Board. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe the adoption of any of these accounting pronouncements has had or will have a material impact on the Company’s consolidated financial statements.

GOING CONCERN

GOING CONCERN	12 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	3. GOING CONCERN The Company adopted Accounting Standards Update No. 2014-15, “Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”) The Company is commencing operations to generate sufficient revenue; however, the Company’s cash position may not be sufficient to support the Company’s daily operations. Management intends to raise additional funds by way of a private or public offering. While the Company believes in the viability of its strategy to commence operations and generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds by way of private offering. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

RELATED PARTIES

RELATED PARTIES	12 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTIES	4. RELATED PARTIES The Company outsources its manufacturing pursuant to a Contract Services Agreement with DryRX, LLC dated as of January 1, 2020, which replaced and superseded the Contract Services Agreement with DryRX, LLC dated as of July 22, 2018, which expired in accordance with its terms. The Contract Services Agreement, among other things, provides that DryRX shall provide manufacturing and support services on behalf of the Company, and shall be responsible for the manufacturing oversight and production operations of the Company’s products. In return, the Company is obligated to pay to DryRX a fee equal to 10% of net sales less cost-of-goods-sold and all expenses associated with the services. DryRX is owned and controlled by Steve Howe’s brother. As at March 31, 2022, the Company has recorded a royalty liability of $115,872 and is on the consolidated balance sheet. No royalty has been paid as of the date of this filing. The Company entered into a Consulting Agreement with Massagewave, Inc, owned and controlled by Steve Howe, to assist with business development and administrative activities. The agreement was entered into on May 1, 2018 and had required monthly payments of $ 15,000 April 30, 2020 13,620 244,186 0 1,500

FIXED ASSETS

FIXED ASSETS	12 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
FIXED ASSETS	5. FIXED ASSETS The carrying basis and accumulated depreciation of fixed assets at March 31, 2022 and 2021 is as follows: SCHEDULE OF FIXED ASSETS Useful Lives March 31, 2022 March 31, 2021 Equipment in use 5 $ 182,620 $ 99,000 Equipment at 3 rd 5 212,000 212,000 Building and Improvements 40 254,446 68,815 Vehicles and trailers 5 60,266 60,266 Less depreciation (194,219 ) (125,704 ) Total fixed assets, net $ 515,113 314,377 The Company recorded depreciation expense of $ 161,641 55,796

LICENSE AGREEMENT, RELATED PART

LICENSE AGREEMENT, RELATED PARTY	12 Months Ended
	Mar. 31, 2022
License Agreement Related Party
LICENSE AGREEMENT, RELATED PARTY	6. LICENSE AGREEMENT, RELATED PARTY On April 30, 2019 the Company entered worldwide exclusive license with Drywave Technologies, Inc. (“Drywave”), a Company owned by Steve Howe. On the terms and conditions of the agreement, the Company received intellectual property rights to manufacture, use, and offer for sale all the products related to the patents and trademarks for dry hydrotherapy therapy technologies. The license fee to acquire the technology was $ 2,000,000 (a) $ 350,000 1,000 (b) $ 200,000 (c) $ 1,450,000 The Company made all the required payments as of March 31, 2021. After payment of the $2,000,000 License Fee and not later than April 30, 2020, the Company began paying to Drywave a royalty of 3% of Net Sales beginning May 1, 2020 and continuing for the longer of the period in which there are valid patent claims or ten years. The Company is performing on this agreement. As at March 31, 2022, the Company has recorded a royalty liability of $ 27,945 The company recorded the original license fee as an intangible asset as of April 30, 2019 and is amortizing the asset over the expected useful life of the asset of 10 150,075 162,500

LEASE LIABILITY

LEASE LIABILITY	12 Months Ended
	Mar. 31, 2022
Lease Liability
LEASE LIABILITY	7. LEASE LIABILITY On January 1, 2022, we adopted ASC Topic 842 – Leases. Under this new guidance, lessees are required to recognize assets and liabilities on the balance sheet for the rights and obligations created by all leases. Upon adoption, we recognized operating lease right-of-use (“ROU”) assets and corresponding lease liabilities of $ 179,563 Lessee accounting We determine if an arrangement is or contains a lease at inception. Our assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period and (3) whether we have the right to direct the use of the asset. Leases are classified as either finance leases or operating leases Under the guidance of ASC 842, operating leases are included in right-of-use assets, current lease liabilities, and noncurrent lease liabilities on our balance sheets. ROU assets and lease liabilities are recognized at commencement date based on the present value of the future minimum lease payments over the lease term. As most of our leases do not provide an implicit interest rate, we use our incremental borrowing rate based on the information available at transition date in determining the present value of future payments. The ROU asset includes any lease payments made but excludes lease incentives and initial direct costs incurred, if any. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Lease extensions Many leases have options to either extend or terminate the lease. In determining the lease term, we considered all available contract extensions that are reasonably certain of occurring. Operating leases The Company has three operating leases, each with different terms. Lease 1 entered into on July 23, 2020 is effective for 3 years and 1 month from the commencement date. The lease requires adjustment upon the annual commencement date with an increase to the monthly rent by 3% Lease 2 entered into on February 24, 2021 is effective for 3 years and 1 month from the commencement date. The lease requires monthly increases until the monthly amount reaches $ 5,000 Lease 3 entered into on April 22, 2021 is effective for 3 years and 1 month from the commencement date. The lease may be renewed with renewal options to be determined at that time. The following table summarizes balance sheet data related to leases at March 31, 2022 and March 31, 2021: SCHEDULE OF BALANCE SHEET RELATED TO LEASES March 31, 2022 March 31, 2021 Assets Operating lease right of use assets #1 $ 71,401 $ - Operating lease right of use assets #2 145,855 - Operating lease right of use assets #3 47,207 - Operating lease right of use assets - - Less accumulated depreciation (104,266 ) - Total operating lease right of use assets $ 160,197 $ - Liabilities Operating lease liability, current 99,464 - Operating lease liability, noncurrent 80,099 - Total lease liabilities 179,563 - Operating lease liability is presented net of lease payments. The Company is required to make monthly payments for each lease. During the year ended March 31, 2022, the Company paid $ 84,899 27,184

NOTES PAYABLE

NOTES PAYABLE	12 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
NOTES PAYABLE	8. NOTES PAYABLE Covid-19 PPP Loan During the year ended March 31, 2021, the Company entered into loans under the Paycheck Protection Program (“PPP”) sponsored by the U.S. Small Business Administration (SBA) providing for proceeds of $ 588,891 1.0 294,066 146,200 148,625 593,546 Senior Secured Notes In June 2021, the Company entered into a Senior Secured Note with Auctus Fund for $ 650,000 55,000 595,000 June 23, 2022 12 78,000 Any principal amount or interest on this note which is not paid when due shall bear interest at the rate of the lesser of (i) sixteen percent (16%) per annum and (ii) the maximum amount permitted by law from the due date thereof until the same is paid. On July 14, 2021, the principal amount of the note was increased by $ 25,000 675,000 Also pursuant to the agreement, in connection with the issuance of the note, the Company issued two common stock purchase warrants (separately, the “First Warrant” and the “Second Warrant” and together, the “Warrants”) to Auctus, each allowing Auctus to purchase an aggregate of 4,333,333 0.15 The total fair value of the warrants was estimated on the issue date at $ 513,827 SCHEDULE OF FAIR VALUE OF THE WARRANTS June 24, 2022 Market price of common stock on date of issuance $ 0.30 Risk-free interest rate 0.48 % Expected dividend yield 0 Expected term (in years) 3 Expected volatility 199.6 % On or about November 22, 2021, the Company triggered an event of default under the Auctus Note and related documents which entitled Auctus, among other things, to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the Auctus Note. On February 17, 2022, Auctus and the Company executed a Waiver Letter which waived such defaults effective as of November 22, 2021. The note is secured by an Affidavit of Confession of Judgment and ranks senior over all existing and future indebtedness of the Borrower. Nonconvertible Notes – Related Party At March 31, 2021, the Company had $ 1,344,625 750,000 3 25,000 725,000 99,970 1,994,655 1,102,735 891,920 SCHEDULE OF NONCONVERTIBLE NOTES RELATED PARTY Interest Rate Issuance Date Maturity March 31, 2022 4 % 12/31/18 12/31/23 $ 55,250 4 % 12/31/18 12/31/21 $ 66,900 4 % 12/31/18 12/31/23 $ 74,220 4 % 9/30/19 9/29/21 $ 314,000 4 % 9/17/19 9/16/20 $ 81,500 4 % 9/30/19 12/31/23 $ 12,450 1 % 12/31/20 12/30/22 $ 254,382 1 % 12/31/20 12/30/22 $ 235,600 1 % 12/31/20 12/30/22 $ 83,785 4 % 12/31/20 12/31/21 $ 53,100 4 % 12/31/20 12/31/21 $ 2,850 12 % 1/10/22 5/10/23 $ 750,000 adjustment $ 10,618 $ 1,994,655 Nonconvertible Notes At March 31, 2021, the Company had $ 1,919,620 370,189 150,000 339,672 1,955,137 1,760,219 189,918 SCHEDULE OF NONCONVERTIBLE NOTES NON RELATED Interest Rate Default Rate Issuance Date Maturity March 31, 2022 14 % N/A 8/1/18 1/31/22 $ 500,000 14.2 % 25 % 9/18/19 9/18/23 $ 23,347 14.2 % 25 % 10/9/19 10/9/23 $ 37,037 14 % Additional 2 % 10/30/19 10/29/21 $ 229,500 14 % Additional 2 % 12/31/19 12/31/20 $ 102,000 14 % N/A 2/5/20 2/5/21 $ 50,000 20 % Additional 2 % 2/25/20 8/24/22 $ 216,000 20 % Additional 2 % 2/28/20 6/30/21 $ 104,000 14.2 % 25 % 3/10/20 3/10/24 $ 90,654 20 % Additional 2 % 4/24/20 4/23/21 $ 20,000 30 % Additional 2 % 10/29/20 2/28/21 $ 25,500 12 % Additional 2 % 10/30/20 11/1/21 $ 25,500 12 % Additional 2 % 10/30/20 11/1/21 $ 25,500 20 % N/A % 2/2/21 5/31/22 $ 45,000 15 % N/A % 4/1/21 3/31/24 $ 38,880 10 % N/A % 4/1/21 3/31/22 $ 100,000 N/A % N/A % 8/11/21 12/31/21 $ 322,219 $ 1,955,137 Convertible Notes – Related Party The Company has issued $ 29,970 4 2 Maturity Date 8 29,970 29,970 Convertible Notes At March 31, 2021, the Company had $ 1,107,143 1,387,800 1,390,000 905,500 5,883,564 1,257,225 360,000 1,229,443 SCHEDULE OF CONVERTIBLE NOTES Interest Rate Conversion Rate Issuance Date Maturity March 31, 2022 12 % $ 1.80 5/5/19 1/26/21 $ 102,000 12 % $ 1.80 7/10/19 7/9/21 $ 153,000 12 % $ 1.80 2/12/20 2/11/21 $ 102,000 8 % $ 0.22 3/9/21 3/8/22 $ 100,000 2 % $ 0.30 6/16/21 3/31/22 $ 250,000 10 % $ 0.30 6/22/21 6/21/22 $ 50,000 10 % $ 7.50 8/30/21 8/29/22 $ 150,000 10 % $ 7.50 8/31/21 8/30/22 $ 75,000 10 % $ - * 8/31/21 8/30/22 $ 50,000 10 % $ - * 9/15/21 9/14/22 $ 20,000 10 % $ - * 9/20/21 9/19/22 $ 10,000 10 % $ - * 9/22/21 9/21/22 $ 10,000 10 % $ - * 10/13/21 10/12/22 $ 50,000 10 % $ 7.50 10/18/21 10/17/22 $ 25,000 10 % $ 7.50 10/20/21 10/19/22 $ 20,000 10 % $ - * 10/28/21 10/27/22 $ 20,000 10 % $ - * 12/27/21 12/26/22 $ 20,000 10 % $ - * 2/11/22 2/10/23 $ 10,000 10 % $ - * 2/22/22 2/21/23 $ 5,000 adjustment $ 7,443 $ 1,229,443 * Upon commencement by the Company of a Qualified Financing, all of the outstanding principal and interest shall convert into that number of shares of New Round Stock, based upon a conversion price equal to the actual price per share of New Round Stock in the Qualified Financing. If not converted prior to the twelve-month anniversary of the issuance of the Notes, the Notes will be payable upon demand. Prepayment is not permitted prior to a payoff event. The Company evaluates these notes at commencement for beneficial conversion features and derivatives. During the year ended March 31, 2022, the Company recorded a beneficial conversion feature on the convertible notes of $ 914,076 0 The following table depicts the total notes payable at March 31, 2022 and March 31, 2021: SCHEDULE OF NOTE PAYABLE OUTSTANDING BALANCE March 31, 2022 March 31, 2021 PPP Loan $ - $ 588,891 Senior secured notes $ 675,000 $ - Nonconvertible notes - related party $ 1,994,655 $ 1,344,625 Nonconvertible notes $ 1,955,137 $ 1,919,620 Convertible notes - related party $ 29,970 $ 29,970 Convertible notes $ 1,229,443 $ 1,107,143 Less: Non-current portion of senior secured notes $ 675,000 $ - Non-current portion of PPP Loan $ - $ (588,891 ) Non-current portion of nonconvertible notes - related party $ (891,920 ) $ (509,972 ) Non-current portion of nonconvertible notes $ (189,918 ) $ (174,620 ) Current notes payable $ 4,127,367 $ 3,716,766

SHAREHOLDERS_ EQUITY (DEFECIT)

SHAREHOLDERS’ EQUITY (DEFECIT)	12 Months Ended
	Mar. 31, 2022
Equity [Abstract]
SHAREHOLDERS’ EQUITY (DEFECIT)	9. SHAREHOLDERS’ EQUITY (DEFECIT) Common Stock The Company is authorized to issue 1,500,000,000 0.001 a. One non-cumulative vote for each share held of record on all matters submitted to a vote of the stockholders; b. To participate equally and to receive any and all such dividends as may be declared by the Board of Directors out of funds legally available therefore; and c. To participate pro rata in any distribution of assets available for distribution upon liquidation. Stockholders have no pre-emptive rights to acquire additional shares of common stock or any other securities. Common shares are not subject to redemption and carry no subscription or conversion rights. During the year ended March 31, 2022, the Company converted $ 824,383 4,626,339 150,867 150,867 1,257,225 During the year ended March 31, 2022, the Company issued 1,600,000 15,000 50,000 During the year ended March 31, 2022, the Company issued 1,314,827 64,500 215,000 166,667 0.30 The total fair value of the warrants was estimated on the issue date at $ 53,833 SCHEDULE OF FAIR VALUE OF THE WARRANTS June 16, 2022 Market price of common stock on date of issuance $ 0.35 Risk-free interest rate 0.41 % Expected dividend yield 0 Expected term (in years) 3 Expected volatility 200.4 % In July 2021, the Company issued 454,545 0.22 100,000 In March 2022, the Company sold 1,742,425 0.16 287,500 757,575 0.17 125,000 Preferred Stock On April 6, 2021, the Company increased its authorized shares of “blank check” preferred stock from 10,000,000 150,000,000 No The Company has not declared or paid any dividends or returned any capital to common stock shareholders as of March 31, 2022 and 2021.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	10. INCOME TAXES Income Tax Expense For the fiscal year ended March 31, 2022, the reconciliation between the income tax benefit computed by applying the statutory U.S. federal income tax rate to the pre-tax loss before income taxes, and total income tax expense recognized in the financial statements is the change in the valuation allowance. For the fiscal year ended March 31, 2022 and 2021, the Company did not recognize any current income tax expense or benefit due to a full valuation allowance on its deferred income tax assets. Deferred Income Tax Assets As of March 31, 2022 and 2021, the income tax effects of temporary differences that give rise to significant deferred income tax assets and liabilities are as follows (in thousands): SUMMARY OF SIGNIFICANT DEFERRED INCOME TAX ASSETS AND LIABILITIES March 31, 2022 March 31, 2021 Deferred income tax assets: Net operating loss carryforwards - - Other - - Total deferred income tax assets - - Valuation allowance for deferred income tax assets - - Net deferred income tax assets - - For the fiscal years ended March 31, 2022 and 2021, the valuation allowance increased primarily as a result of the increase in net operating losses. In assessing the realizability of deferred income tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. NOL Carryforwards and Other Matters The Company files income tax returns in the U.S. federal jurisdiction and the state of Colorado. The Company’s federal and state tax years for the 2018 fiscal year and forward are subject to examination by taxing authorities. The Company did not have any unrecognized tax benefits as of March 31, 2022 and 2021. The Company’s policy is to account for any interest expense and penalties for unrecognized tax benefits as part of the income tax provision. The Company does not anticipate that unrecognized tax benefits will significantly increase or decrease within the next twelve months.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	11. COMMITMENTS AND CONTINGENCIES Off-Balance Sheet Arrangements – Legal Matters

RESTATEMENT

RESTATEMENT	12 Months Ended
	Mar. 31, 2022
Accounting Changes and Error Corrections [Abstract]
RESTATEMENT	12. RESTATEMENT The Company amended its Annual Report on Form 10-K for the fiscal year ended March 31, 2021 (the “Original Filing”), to restate its audited consolidated financial statements and related footnote disclosures to retroactively report an April 6, 2021, 15-1 forward stock split and delete the incorrect leases of inventory revenue disclosure statement for the period covered in the Original Filing. The Company currently does not hold any leases of inventory and has removed this disclosure from the footnotes of the financial statements in the Amendment No. 1 to the Original Filing, instead providing that the Company derives its revenues primarily from the usage fees and sales of hydrotherapy massage beds and installation services. Revenues from sales are recognized when the products are sold and delivered to its customers and the usage fees are earned based on subscription or actual usage. Sales Taxes and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Shipping and handling fees charged to customers are reported within revenue. In addition, the weighted average earnings per share have been recalculated in the Consolidated Balance Sheets in the Amendment No. 1 to the Original Filing.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	13. SUBSEQUENT EVENTS The Company entered into a loan agreement with 1800 Diagonal Lending LLC., a Virginia limited liability company, for the sum of $ 70,000.00 November 15, 2023 The Company entered into a loan agreement with GS Capital Partners LLC, for the aggregate principal amount of $ 55,000 May 17, 2023

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation
Principles of Consolidation	Principles of Consolidation
Accounting Estimates	Accounting Estimates
Risks and Uncertainties	Risks and Uncertainties
Loss Per Common Share	Loss Per Common Share 227,242,753 191,762,740
Cash	Cash
Accounts Receivable	Accounts Receivable 206,949 38,341 Other Receivable 410,000 410,000 0
Related Party Transactions	Related Party Transactions
Advance Payments on Purchases of Inventory, related party	Advance Payments on Purchases of Inventory, related party 0 16,000
Fixed Assets	Fixed Assets 194,219 108,746
Patent Cost	Patent Cost 10 550,100 362,500
Leases	Leases
License Payable, related party	License Payable, related party
Warranty Liability	Warranty Liability
Beneficial Conversion Features	Beneficial Conversion Features
Derivatives	Derivatives
Revenue	Revenue The Company derives its revenues primarily from the usage fees and sales of hydrotherapy massage beds and installation services. Revenues from sales are recognized when the products are sold and delivered to its customers and the usage fees are earned based on subscription or actual usage. Sales taxes and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Shipping and handling fees charged to customers are reported within revenue.
Income Taxes	Income Taxes The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary. Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value Measurements and Disclosures ● Level 1: Quoted prices for identical assets and liabilities in active markets; ● Level 2: Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and ● Level 3: Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amounts of financial instruments including cash, accounts payable, warrant liability and notes payable approximated fair value as of March 31, 2022 and 2021 due to the relatively short maturity of the respective instruments.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements – Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments In August 2020, the FASB issued ASU 2020-06 , Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Derivatives and Hedging Derivatives and Hedging—Contracts in Entity’s Own Equity As of March 31, 2022, there were several new accounting pronouncements issued by the Financial Accounting Standards Board. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe the adoption of any of these accounting pronouncements has had or will have a material impact on the Company’s consolidated financial statements.

FIXED ASSETS (Tables)

FIXED ASSETS (Tables)	12 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
SCHEDULE OF FIXED ASSETS	The carrying basis and accumulated depreciation of fixed assets at March 31, 2022 and 2021 is as follows: SCHEDULE OF FIXED ASSETS Useful Lives March 31, 2022 March 31, 2021 Equipment in use 5 $ 182,620 $ 99,000 Equipment at 3 rd 5 212,000 212,000 Building and Improvements 40 254,446 68,815 Vehicles and trailers 5 60,266 60,266 Less depreciation (194,219 ) (125,704 ) Total fixed assets, net $ 515,113 314,377

LEASE LIABILITY (Tables)

LEASE LIABILITY (Tables)	12 Months Ended
	Mar. 31, 2022
Lease Liability
SCHEDULE OF BALANCE SHEET RELATED TO LEASES	The following table summarizes balance sheet data related to leases at March 31, 2022 and March 31, 2021: SCHEDULE OF BALANCE SHEET RELATED TO LEASES March 31, 2022 March 31, 2021 Assets Operating lease right of use assets #1 $ 71,401 $ - Operating lease right of use assets #2 145,855 - Operating lease right of use assets #3 47,207 - Operating lease right of use assets - - Less accumulated depreciation (104,266 ) - Total operating lease right of use assets $ 160,197 $ - Liabilities Operating lease liability, current 99,464 - Operating lease liability, noncurrent 80,099 - Total lease liabilities 179,563 -

NOTES PAYABLE (Tables)

NOTES PAYABLE (Tables)	12 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
SCHEDULE OF FAIR VALUE OF THE WARRANTS	SCHEDULE OF FAIR VALUE OF THE WARRANTS June 24, 2022 Market price of common stock on date of issuance $ 0.30 Risk-free interest rate 0.48 % Expected dividend yield 0 Expected term (in years) 3 Expected volatility 199.6 %
SCHEDULE OF NONCONVERTIBLE NOTES RELATED PARTY	SCHEDULE OF NONCONVERTIBLE NOTES RELATED PARTY Interest Rate Issuance Date Maturity March 31, 2022 4 % 12/31/18 12/31/23 $ 55,250 4 % 12/31/18 12/31/21 $ 66,900 4 % 12/31/18 12/31/23 $ 74,220 4 % 9/30/19 9/29/21 $ 314,000 4 % 9/17/19 9/16/20 $ 81,500 4 % 9/30/19 12/31/23 $ 12,450 1 % 12/31/20 12/30/22 $ 254,382 1 % 12/31/20 12/30/22 $ 235,600 1 % 12/31/20 12/30/22 $ 83,785 4 % 12/31/20 12/31/21 $ 53,100 4 % 12/31/20 12/31/21 $ 2,850 12 % 1/10/22 5/10/23 $ 750,000 adjustment $ 10,618 $ 1,994,655
SCHEDULE OF NONCONVERTIBLE NOTES NON RELATED	SCHEDULE OF NONCONVERTIBLE NOTES NON RELATED Interest Rate Default Rate Issuance Date Maturity March 31, 2022 14 % N/A 8/1/18 1/31/22 $ 500,000 14.2 % 25 % 9/18/19 9/18/23 $ 23,347 14.2 % 25 % 10/9/19 10/9/23 $ 37,037 14 % Additional 2 % 10/30/19 10/29/21 $ 229,500 14 % Additional 2 % 12/31/19 12/31/20 $ 102,000 14 % N/A 2/5/20 2/5/21 $ 50,000 20 % Additional 2 % 2/25/20 8/24/22 $ 216,000 20 % Additional 2 % 2/28/20 6/30/21 $ 104,000 14.2 % 25 % 3/10/20 3/10/24 $ 90,654 20 % Additional 2 % 4/24/20 4/23/21 $ 20,000 30 % Additional 2 % 10/29/20 2/28/21 $ 25,500 12 % Additional 2 % 10/30/20 11/1/21 $ 25,500 12 % Additional 2 % 10/30/20 11/1/21 $ 25,500 20 % N/A % 2/2/21 5/31/22 $ 45,000 15 % N/A % 4/1/21 3/31/24 $ 38,880 10 % N/A % 4/1/21 3/31/22 $ 100,000 N/A % N/A % 8/11/21 12/31/21 $ 322,219 $ 1,955,137
SCHEDULE OF CONVERTIBLE NOTES	SCHEDULE OF CONVERTIBLE NOTES Interest Rate Conversion Rate Issuance Date Maturity March 31, 2022 12 % $ 1.80 5/5/19 1/26/21 $ 102,000 12 % $ 1.80 7/10/19 7/9/21 $ 153,000 12 % $ 1.80 2/12/20 2/11/21 $ 102,000 8 % $ 0.22 3/9/21 3/8/22 $ 100,000 2 % $ 0.30 6/16/21 3/31/22 $ 250,000 10 % $ 0.30 6/22/21 6/21/22 $ 50,000 10 % $ 7.50 8/30/21 8/29/22 $ 150,000 10 % $ 7.50 8/31/21 8/30/22 $ 75,000 10 % $ - * 8/31/21 8/30/22 $ 50,000 10 % $ - * 9/15/21 9/14/22 $ 20,000 10 % $ - * 9/20/21 9/19/22 $ 10,000 10 % $ - * 9/22/21 9/21/22 $ 10,000 10 % $ - * 10/13/21 10/12/22 $ 50,000 10 % $ 7.50 10/18/21 10/17/22 $ 25,000 10 % $ 7.50 10/20/21 10/19/22 $ 20,000 10 % $ - * 10/28/21 10/27/22 $ 20,000 10 % $ - * 12/27/21 12/26/22 $ 20,000 10 % $ - * 2/11/22 2/10/23 $ 10,000 10 % $ - * 2/22/22 2/21/23 $ 5,000 adjustment $ 7,443 $ 1,229,443 * Upon commencement by the Company of a Qualified Financing, all of the outstanding principal and interest shall convert into that number of shares of New Round Stock, based upon a conversion price equal to the actual price per share of New Round Stock in the Qualified Financing. If not converted prior to the twelve-month anniversary of the issuance of the Notes, the Notes will be payable upon demand. Prepayment is not permitted prior to a payoff event.
SCHEDULE OF NOTE PAYABLE OUTSTANDING BALANCE	The following table depicts the total notes payable at March 31, 2022 and March 31, 2021: SCHEDULE OF NOTE PAYABLE OUTSTANDING BALANCE March 31, 2022 March 31, 2021 PPP Loan $ - $ 588,891 Senior secured notes $ 675,000 $ - Nonconvertible notes - related party $ 1,994,655 $ 1,344,625 Nonconvertible notes $ 1,955,137 $ 1,919,620 Convertible notes - related party $ 29,970 $ 29,970 Convertible notes $ 1,229,443 $ 1,107,143 Less: Non-current portion of senior secured notes $ 675,000 $ - Non-current portion of PPP Loan $ - $ (588,891 ) Non-current portion of nonconvertible notes - related party $ (891,920 ) $ (509,972 ) Non-current portion of nonconvertible notes $ (189,918 ) $ (174,620 ) Current notes payable $ 4,127,367 $ 3,716,766

SHAREHOLDERS_ EQUITY (DEFECIT)

SHAREHOLDERS’ EQUITY (DEFECIT) (Tables)	12 Months Ended
	Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
SCHEDULE OF FAIR VALUE OF THE WARRANTS	SCHEDULE OF FAIR VALUE OF THE WARRANTS June 24, 2022 Market price of common stock on date of issuance $ 0.30 Risk-free interest rate 0.48 % Expected dividend yield 0 Expected term (in years) 3 Expected volatility 199.6 %
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
SCHEDULE OF FAIR VALUE OF THE WARRANTS	SCHEDULE OF FAIR VALUE OF THE WARRANTS June 16, 2022 Market price of common stock on date of issuance $ 0.35 Risk-free interest rate 0.41 % Expected dividend yield 0 Expected term (in years) 3 Expected volatility 200.4 %

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
SUMMARY OF SIGNIFICANT DEFERRED INCOME TAX ASSETS AND LIABILITIES	As of March 31, 2022 and 2021, the income tax effects of temporary differences that give rise to significant deferred income tax assets and liabilities are as follows (in thousands): SUMMARY OF SIGNIFICANT DEFERRED INCOME TAX ASSETS AND LIABILITIES March 31, 2022 March 31, 2021 Deferred income tax assets: Net operating loss carryforwards - - Other - - Total deferred income tax assets - - Valuation allowance for deferred income tax assets - - Net deferred income tax assets - -

NATURE OF OPERATIONS (Details N

NATURE OF OPERATIONS (Details Narrative) - USD ($)							12 Months Ended
	Apr. 06, 2021	Apr. 06, 2021	Jan. 05, 2021	Apr. 17, 2020	Mar. 05, 2020	Jun. 25, 2019	Mar. 31, 2022	Mar. 31, 2021	Mar. 04, 2020
Entity incorporation, date of incorporation							Mar. 02, 2016
Entity Incorporation, State or Country Code							NV
Common stock, shares authorized					100,000,000		1,500,000,000	1,500,000,000	75,000,000
Preferred stock authorized							150,000,000	150,000,000
Stockholders equity description					12.6374:1
Common stock, par value							$ 0.001	$ 0.001
Minimum [Member]
Common stock, shares authorized	100,000,000	100,000,000
Preferred stock authorized	10,000,000	10,000,000
Maximum [Member]
Common stock, shares authorized	1,500,000,000	1,500,000,000
Preferred stock authorized	150,000,000	150,000,000
Exchange Agreement [Member] | Mr. Amer Samad [Member] | Bed Therapies Inc [Member]
Stockholders equity description	Company filed a Certificate of Change with the Secretary of State of the State of Nevada to (i) increase the Company’s authorized shares of common stock from 100,000,000 to 1,500,000,000, (ii) increase the Company’s authorized shares of “blank check” preferred stock from 10,000,000 to 150,000,000, and (iii) effect a 1:15 forward stock split of the common stock.
Blank Check [Member]
Preferred stock authorized					10,000,000
Maksim Charniak [Member]
Equity method investment description							On June 25, 2019, Maksim Charniak, the Company’s then sole executive officer and director and the owner of 3,000,000 shares (pre-stock split) of the Company’s common stock, sold all of his shares of common stock of the Company to Amer Samad, resulting in a change of control of the Company. As part of that transaction, Mr. Charniak resigned from all of his officer and director positions, and Mr. Samad was appointed as the Chief Executive Officer, President, Chief Financial Officer and Secretary of the Company, and was appointed to the Board of Directors of the Company. Mr. Samad also purchased 1,167,937 shares (pre-stock split) of the Company’s common stock in a series of private transactions, resulting in Mr. Samad owning 4,167,937 shares (pre-stock split) of the Company’s common stock, or approximately 95.6% of the issued and outstanding common stock of the Company
Mr. Amer Samad [Member]
Stock issued during period shares stock splits						3,000,000
Ownership percentage						95.60%
Bed Therapies Inc [Member] | Exchange Agreement [Member]
Stock issued during period shares stock splits			1,269,665
Ownership percentage				100%
Stockholders equity description		Accordingly, the Company acquired 100% of Omnia Corp. in exchange for the issuance of 10,000,000 (not adjusted to reflect the Company’s 15:1 forward stock split on April 6, 2021) shares of the Company’s common stock and Omnia Corp. became the Company’s wholly-owned subsidiary. As of the closing of the Acquisition (the “Closing”), Mr. Samad, resigned as an officer and director of the Company and agreed to cancel 52,656,888
Common stock, par value				$ 0.001
Debt Conversion, Converted Instrument, Amount				$ 539,000
Bed Therapies Inc [Member] | Exchange Agreement [Member] | Mr. Amer Samad [Member]
Cancellation of stock split				52,656,888

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)		12 Months Ended
	Apr. 30, 2019	Mar. 31, 2022	Mar. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Number of anti-dilutive common stock		227,242,753	191,762,740
Accounts receivable		$ 206,949	$ 38,341
Other receivable		410,000	0
Advances on inventory			16,000
Accumulated depreciation		$ 194,219	108,746
Intangible asset expected life	10 years	10 years
Accumulated amortization		$ 550,100	$ 362,500
Income tax descripition		The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.
Drywave Technologies, Inc. [Member]
Defined Benefit Plan Disclosure [Line Items]
Other receivable		$ 410,000

RELATED PARTIES (Details Narrat

RELATED PARTIES (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Related Party Transaction [Line Items]
Payments of related party		$ 1,100,394
Accounts payable, related parties, current		1,500
Consulting Agreement [Member]
Related Party Transaction [Line Items]
Related party transaction, description	The Company entered into a Consulting Agreement with Massagewave, Inc, owned and controlled by Steve Howe, to assist with business development and administrative activities. The agreement was entered into on May 1, 2018 and had required monthly payments of $15,000 per month. The agreement expired on April 30, 2020 with renewal options.
Agreement expires date	Apr. 30, 2020
Consulting expense, related party	$ 13,620	244,186
Accounts payable, related parties, current		$ 1,500
Consulting Agreement [Member] | Massagewave Inc [Member]
Related Party Transaction [Line Items]
Payments of related party	$ 15,000

SCHEDULE OF FIXED ASSETS (Detai

SCHEDULE OF FIXED ASSETS (Details) - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Property, Plant and Equipment [Line Items]
Less depreciation	$ (194,219)	$ (125,704)
Total fixed assets, net	$ 515,113	314,377
Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Property plant and equipment gross	$ 182,620	99,000
Equipment at 3rd Party Locations [Member]
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Property plant and equipment gross	$ 212,000	212,000
Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Useful lives	40 years
Property plant and equipment gross	$ 254,446	68,815
Vehicles and Trailers [Member]
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Property plant and equipment gross	$ 60,266	$ 60,266

FIXED ASSETS (Details Narrative

FIXED ASSETS (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 161,641	$ 55,796

LICENSE AGREEMENT, RELATED PA_2

LICENSE AGREEMENT, RELATED PARTY (Details Narrative) - USD ($)				12 Months Ended
	Mar. 02, 2020	Oct. 30, 2019	Apr. 30, 2019	Mar. 31, 2022	Mar. 31, 2021	Aug. 30, 2019
Defined Benefit Plan Disclosure [Line Items]
Payment to acquire technology	$ 1,450,000	$ 200,000	$ 350,000		$ 1,801,000
Payment of escrow fee			$ 1,000
Royalty liability				$ 27,945
Finite-lived intangible asset, useful life			10 years	10 years
Amortization of intangible assets				$ 150,075	$ 162,500
Drywave Technologies, Inc. [Member]
Defined Benefit Plan Disclosure [Line Items]
Related Party Transaction, Description of Transaction					After payment of the $2,000,000 License Fee and not later than April 30, 2020, the Company began paying to Drywave a royalty of 3% of Net Sales beginning May 1, 2020 and continuing for the longer of the period in which there are valid patent claims or ten years. The Company is performing on this agreement. As at March 31, 2022, the Company has recorded a royalty liability of $27,945 and is on the consolidated balance sheet. No royalty has been paid as of the date of this filing.
Drywave Technologies, Inc. [Member] | License Agreement [Member]
Defined Benefit Plan Disclosure [Line Items]
Accounts Payable, Related Parties						$ 2,000,000

SCHEDULE OF BALANCE SHEET RELAT

SCHEDULE OF BALANCE SHEET RELATED TO LEASES (Details) - USD ($)	Mar. 31, 2022	Jan. 01, 2022	Mar. 31, 2021
Assets
Operating lease right of use assets
Less accumulated depreciation	(104,266)
Total operating lease right of use assets	160,197	$ 179,563
Liabilities
Operating lease liability, current	99,464
Operating lease liability, noncurrent	80,099
Total lease liabilities	179,563
Lease One Agreement [Member]
Assets
Operating lease right of use assets	71,401
Lease Two Agreement [Member]
Assets
Operating lease right of use assets	145,855
Lease Three Agreement [Member]
Assets
Operating lease right of use assets	$ 47,207

LEASE LIABILITY (Details Narrat

LEASE LIABILITY (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2022	Jan. 01, 2022	Mar. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Operating lease right of use asset	$ 160,197	$ 179,563
Lessee, operating lease, description	Our assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period and (3) whether we have the right to direct the use of the asset. Leases are classified as either finance leases or operating leases
Cash paid for lease	$ 84,899
Interest expense	$ 27,184
Lease One Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lessee, operating lease, description	Lease 1 entered into on July 23, 2020 is effective for 3 years and 1 month from the commencement date. The lease requires adjustment upon the annual commencement date with an increase to the monthly rent by 3%
Lease Two Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lessee, operating lease, description	Lease 2 entered into on February 24, 2021 is effective for 3 years and 1 month from the commencement date. The lease requires monthly increases until the monthly amount reaches $5,000, then a 3% annual increase thereafter
Cash paid for lease	$ 5,000
Lease Three Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lessee, operating lease, description	Lease 3 entered into on April 22, 2021 is effective for 3 years and 1 month from the commencement date. The lease may be renewed with renewal options to be determined at that time.

SCHEDULE OF FAIR VALUE OF THE W

SCHEDULE OF FAIR VALUE OF THE WARRANTS (Details)	Jun. 24, 2022	Jun. 16, 2022
Measurement Input Market Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected volatility	0.30	0.35
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected volatility	0.48	0.41
Measurement Input, Expected Dividend Payment [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected volatility	0	0
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected term (in years)	3 years	3 years
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected volatility	199.6	200.4

SCHEDULE OF NONCONVERTIBLE NOTE

SCHEDULE OF NONCONVERTIBLE NOTES RELATED PARTY (Details)	12 Months Ended
	Mar. 31, 2022 USD ($)
Nonconvertible Notes Related Party One [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Dec. 31, 2018
Maturity	Dec. 31, 2023
Unsecured Debt	$ 55,250
Nonconvertible Notes Related Party Two [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Dec. 31, 2018
Maturity	Dec. 31, 2021
Unsecured Debt	$ 66,900
Nonconvertible Notes Related Party Three [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Dec. 31, 2018
Maturity	Dec. 31, 2023
Unsecured Debt	$ 74,220
Nonconvertible Notes Related Party Four [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Sep. 30, 2019
Maturity	Sep. 29, 2021
Unsecured Debt	$ 314,000
Nonconvertible Notes Related Party Five [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Sep. 17, 2019
Maturity	Sep. 16, 2020
Unsecured Debt	$ 81,500
Nonconvertible Notes Related Party Six [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Sep. 30, 2019
Maturity	Dec. 31, 2023
Unsecured Debt	$ 12,450
Nonconvertible Notes Related Party Seven [Member]
Short-Term Debt [Line Items]
Interest Rate	1%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Debt	$ 254,382
Nonconvertible Notes Related Party Eight [Member]
Short-Term Debt [Line Items]
Interest Rate	1%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Debt	$ 235,600
Nonconvertible Notes Related Party Nine [Member]
Short-Term Debt [Line Items]
Interest Rate	1%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Debt	$ 83,785
Nonconvertible Notes Related Party Ten [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 31, 2021
Unsecured Debt	$ 53,100
Nonconvertible Notes Related Party Eleven [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 31, 2021
Unsecured Debt	$ 2,850
Nonconvertible Notes Related Party Twelve [Member]
Short-Term Debt [Line Items]
Interest Rate	12%
Issuance Date	Jan. 10, 2022
Maturity	May 10, 2023
Unsecured Debt	$ 750,000
Nonconvertible Notes Related Party Thirteen [Member]
Short-Term Debt [Line Items]
Unsecured Debt	10,618
Nonconvertible Notes Related Party [Member]
Short-Term Debt [Line Items]
Unsecured Debt	$ 1,994,655

SCHEDULE OF NONCONVERTIBLE NO_2

SCHEDULE OF NONCONVERTIBLE NOTES NON RELATED (Details)	12 Months Ended
	Mar. 31, 2022 USD ($)
Nonconvertible Notes Non Related One [Member]
Short-Term Debt [Line Items]
Interest Rate	14%
Issuance Date	Aug. 01, 2018
Maturity	Jan. 31, 2022
Unsecured Notes Payable	$ 500,000
Nonconvertible Notes Non Related Two [Member]
Short-Term Debt [Line Items]
Interest Rate	14.20%
Issuance Date	Sep. 18, 2019
Maturity	Sep. 18, 2023
Unsecured Notes Payable	$ 23,347
Debt instrument, default rate	25%
Nonconvertible Notes Non Related Three [Member]
Short-Term Debt [Line Items]
Interest Rate	14.20%
Issuance Date	Oct. 09, 2019
Maturity	Oct. 09, 2023
Unsecured Notes Payable	$ 37,037
Debt instrument, default rate	25%
Nonconvertible Notes Non Related Four [Member]
Short-Term Debt [Line Items]
Interest Rate	14%
Issuance Date	Oct. 30, 2019
Maturity	Oct. 29, 2021
Unsecured Notes Payable	$ 229,500
Debt instrument, default rate	2%
Nonconvertible Notes Non Related Five [Member]
Short-Term Debt [Line Items]
Interest Rate	14%
Issuance Date	Dec. 31, 2019
Maturity	Dec. 31, 2020
Unsecured Notes Payable	$ 102,000
Debt instrument, default rate	2%
Nonconvertible Notes Non Related Six [Member]
Short-Term Debt [Line Items]
Interest Rate	14%
Issuance Date	Feb. 05, 2020
Maturity	Feb. 05, 2021
Unsecured Notes Payable	$ 50,000
Nonconvertible Notes Non Related Seven [Member]
Short-Term Debt [Line Items]
Interest Rate	20%
Issuance Date	Feb. 25, 2020
Maturity	Aug. 24, 2022
Unsecured Notes Payable	$ 216,000
Debt instrument, default rate	2%
Nonconvertible Notes Non Related Eight [Member]
Short-Term Debt [Line Items]
Interest Rate	20%
Issuance Date	Feb. 28, 2020
Maturity	Jun. 30, 2021
Unsecured Notes Payable	$ 104,000
Debt instrument, default rate	2%
Nonconvertible Notes Non Related Nine [Member]
Short-Term Debt [Line Items]
Interest Rate	14.20%
Issuance Date	Mar. 10, 2020
Maturity	Mar. 10, 2024
Unsecured Notes Payable	$ 90,654
Debt instrument, default rate	25%
Nonconvertible Notes Non Related Ten [Member]
Short-Term Debt [Line Items]
Interest Rate	20%
Issuance Date	Apr. 24, 2020
Maturity	Apr. 23, 2021
Unsecured Notes Payable	$ 20,000
Debt instrument, default rate	2%
Nonconvertible Notes Non Related Eleven [Member]
Short-Term Debt [Line Items]
Interest Rate	30%
Issuance Date	Oct. 29, 2020
Maturity	Feb. 28, 2021
Unsecured Notes Payable	$ 25,500
Debt instrument, default rate	2%
Nonconvertible Notes Non Related Twelve [Member]
Short-Term Debt [Line Items]
Interest Rate	12%
Issuance Date	Oct. 30, 2020
Maturity	Nov. 01, 2021
Unsecured Notes Payable	$ 25,500
Debt instrument, default rate	2%
Nonconvertible Notes Non Related Thirteen [Member]
Short-Term Debt [Line Items]
Interest Rate	12%
Issuance Date	Oct. 30, 2020
Maturity	Nov. 01, 2021
Unsecured Notes Payable	$ 25,500
Debt instrument, default rate	2%
Nonconvertible Notes Non Related Fourteen [Member]
Short-Term Debt [Line Items]
Interest Rate	20%
Issuance Date	Feb. 02, 2021
Maturity	May 31, 2022
Unsecured Notes Payable	$ 45,000
Nonconvertible Notes Non Related Fifteen [Member]
Short-Term Debt [Line Items]
Interest Rate	15%
Issuance Date	Apr. 01, 2021
Maturity	Mar. 31, 2024
Unsecured Notes Payable	$ 38,880
Nonconvertible Notes Non Related Sixteen [Member]
Short-Term Debt [Line Items]
Interest Rate	10%
Issuance Date	Apr. 01, 2021
Maturity	Mar. 31, 2022
Unsecured Notes Payable	$ 100,000
Nonconvertible Notes Non Related Seventeen [Member]
Short-Term Debt [Line Items]
Issuance Date	Aug. 11, 2021
Maturity	Dec. 31, 2021
Unsecured Notes Payable	$ 322,219
Nonconvertible Notes Non Related [Member]
Short-Term Debt [Line Items]
Unsecured Notes Payable	$ 1,955,137

SCHEDULE OF CONVERTIBLE NOTES (

SCHEDULE OF CONVERTIBLE NOTES (Details)	12 Months Ended
	Mar. 31, 2022 USD ($) $ / shares
Convertible Notes One [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	12%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 1.80
Issuance Date	May 05, 2019
Maturity	Jan. 26, 2021
Unsecured Notes Payable	$ 102,000
Convertible Notes Two [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	12%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 1.80
Issuance Date	Jul. 10, 2019
Maturity	Jul. 09, 2021
Unsecured Notes Payable	$ 153,000
Convertible Notes Three [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	12%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 1.80
Issuance Date	Feb. 12, 2020
Maturity	Feb. 11, 2021
Unsecured Notes Payable	$ 102,000
Convertible Notes Four [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	8%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.22
Issuance Date	Mar. 09, 2021
Maturity	Mar. 08, 2022
Unsecured Notes Payable	$ 100,000
Convertible Notes Five [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	2%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.30
Issuance Date	Jun. 16, 2021
Maturity	Mar. 31, 2022
Unsecured Notes Payable	$ 250,000
Convertible Notes Six [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.30
Issuance Date	Jun. 22, 2021
Maturity	Jun. 21, 2022
Unsecured Notes Payable	$ 50,000
Convertible Notes Seven [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 7.50
Issuance Date	Aug. 30, 2021
Maturity	Aug. 29, 2022
Unsecured Notes Payable	$ 150,000
Convertible Notes Eight [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 7.50
Issuance Date	Aug. 31, 2021
Maturity	Aug. 30, 2022
Unsecured Notes Payable	$ 75,000
Convertible Notes Nine [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Aug. 31, 2021
Maturity	Aug. 30, 2022
Unsecured Notes Payable	$ 50,000
Convertible Notes Ten [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Sep. 15, 2021
Maturity	Sep. 14, 2022
Unsecured Notes Payable	$ 20,000
Convertible Notes Eleven [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Sep. 20, 2021
Maturity	Sep. 19, 2022
Unsecured Notes Payable	$ 10,000
Convertible Notes Twelve [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Sep. 22, 2021
Maturity	Sep. 21, 2022
Unsecured Notes Payable	$ 10,000
Convertible Notes Thirteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Oct. 13, 2021
Maturity	Oct. 12, 2022
Unsecured Notes Payable	$ 50,000
Convertible Notes Fourteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 7.50
Issuance Date	Oct. 18, 2021
Maturity	Oct. 17, 2022
Unsecured Notes Payable	$ 25,000
Convertible Notes Fifteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 7.50
Issuance Date	Oct. 20, 2021
Maturity	Oct. 19, 2022
Unsecured Notes Payable	$ 20,000
Convertible Notes Sixteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Oct. 28, 2021
Maturity	Oct. 27, 2022
Unsecured Notes Payable	$ 20,000
Convertible Notes Seventeen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Dec. 27, 2021
Maturity	Dec. 26, 2022
Unsecured Notes Payable	$ 20,000
Convertible Notes Eighteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Feb. 11, 2022
Maturity	Feb. 10, 2023
Unsecured Notes Payable	$ 10,000
Convertible Notes Nineteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Feb. 22, 2022
Maturity	Feb. 21, 2023
Unsecured Notes Payable	$ 5,000
Convertible Notes Twenty [Member]
Short-Term Debt [Line Items]
Unsecured Notes Payable	7,443
Convertible Notes [Member]
Short-Term Debt [Line Items]
Unsecured Notes Payable	$ 1,229,443
[1]Upon commencement by the Company of a Qualified Financing, all of the outstanding principal and interest shall convert into that number of shares of New Round Stock, based upon a conversion price equal to the actual price per share of New Round Stock in the Qualified Financing. If not converted prior to the twelve-month anniversary of the issuance of the Notes, the Notes will be payable upon demand. Prepayment is not permitted prior to a payoff event.

SCHEDULE OF NOTE PAYABLE OUTSTA

SCHEDULE OF NOTE PAYABLE OUTSTANDING BALANCE (Details) - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Short-Term Debt [Line Items]
Current notes payable	$ 4,127,367	$ 3,716,766
PPP Loan [Member]
Short-Term Debt [Line Items]
Current notes payable		588,891
Non-current portion of senior secured notes		588,891
Non-current portion of nonconvertible notes		(588,891)
Senior Secured Notes [Member]
Short-Term Debt [Line Items]
Current notes payable	675,000
Non-current portion of senior secured notes	675,000
Non-current portion of nonconvertible notes	(675,000)
Nonconvertible Notes Related Party [Member]
Short-Term Debt [Line Items]
Current notes payable	1,994,655	1,344,625
Non-current portion of senior secured notes	891,920	509,972
Non-current portion of nonconvertible notes	(891,920)	(509,972)
Nonconvertible Notes [Member]
Short-Term Debt [Line Items]
Current notes payable	1,955,137	1,919,620
Non-current portion of senior secured notes	189,918	174,620
Non-current portion of nonconvertible notes	(189,918)	(174,620)
Convertible Notes Related Party [Member]
Short-Term Debt [Line Items]
Current notes payable	29,970	29,970
Convertible Notes [Member]
Short-Term Debt [Line Items]
Current notes payable	$ 1,229,443	$ 1,107,143

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative) - USD ($)			1 Months Ended				12 Months Ended
	Jul. 14, 2021	Jun. 24, 2021	Oct. 31, 2021	Aug. 31, 2021	Jun. 30, 2021	May 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 30, 2020
Short-Term Debt [Line Items]
Interest rate, percentage							1%
Ppp loan forgiveness			$ 148,625	$ 146,200		$ 294,066	$ 593,546
Secured Debt							675,000
Fair Value Adjustment of Warrants		$ 513,827
Debt instrument, convertible, beneficial conversion feature							914,076	0
Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Proceeds from convertible debt								1,390,000
Convertible debt							1,387,800	1,107,143
Debt instrument converted conversion amount							$ 905,500
Debt instrument converted conversion shares							1,257,225
Repayments of convertible debt							$ 360,000
Convertible Notes Payable [Member] | Common Stock [Member]
Short-Term Debt [Line Items]
Debt instrument converted conversion shares							5,883,564
Convertible Notes Payable [Member] | Related party [Member]
Short-Term Debt [Line Items]
Annual interest rate							4%
Notes Payable, Related Parties							$ 29,970	29,970
Debt instrument default interest rate							2%
Convertible Notes Payable [Member] | Related party [Member] | IPO [Member]
Short-Term Debt [Line Items]
Annual interest rate									8%
Investor [Member] | Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Convertible debt							$ 1,229,443
Auctus Fund LLC [Member] | Warrant [Member] | Securities Purchase Agreement [Member]
Short-Term Debt [Line Items]
Stock Issued During Period, Shares, New Issues	4,333,333
Warrants exercise price	$ 0.15
Paycheck Protection Program Loan [Member]
Short-Term Debt [Line Items]
Proceeds from loan							$ 588,891
Senior Secured Note [Member]
Short-Term Debt [Line Items]
Principal amount	$ 25,000
Secured Debt	$ 675,000
Senior Secured Note [Member] | Auctus Fund LLC [Member]
Short-Term Debt [Line Items]
Principal amount					$ 650,000
Discounted					55,000
Proceeds from Issuance of Senior Long-Term Debt					$ 595,000
Maturity date					Jun. 23, 2022
Annual interest rate							12%
Interest expense							$ 78,000
Debt instrument, description							Any principal amount or interest on this note which is not paid when due shall bear interest at the rate of the lesser of (i) sixteen percent (16%) per annum and (ii) the maximum amount permitted by law from the due date thereof until the same is paid.
Nonconvertible Notes Related Party [Member]
Short-Term Debt [Line Items]
Unsecured notes payable							$ 1,994,655
Nonconvertible Notes Related Party [Member] | Investor [Member]
Short-Term Debt [Line Items]
Unsecured notes payable							1,994,655	1,344,625
Notes Payable, Related Parties							$ 750,000
Debt Instrument, Interest Rate During Period							3%
Debt instrument, interest rate, payment							$ 25,000
Proceeds from convertible debt							725,000
Proceeds (repayments) for notes payable related party							99,970
Unsecured Debt, Current							1,102,735
Unsecured Long-term Debt, Noncurrent							891,920
Nonconvertible Notes [Member]
Short-Term Debt [Line Items]
Notes Payable								$ 1,919,620
Additional notes payable including fees							370,189
Proceeds from Notes Payable							150,000
Repayments of Notes Payable							339,672
Nonconvertible Notes [Member] | Investor [Member]
Short-Term Debt [Line Items]
Notes Payable							1,955,137
Notes Payable, Current							1,760,219
Notes Payable, Noncurrent							$ 189,918

SHAREHOLDERS_ EQUITY (DEFECIT_2

SHAREHOLDERS’ EQUITY (DEFECIT) (Details Narrative) - USD ($)			1 Months Ended		12 Months Ended
	Jun. 24, 2021	Jun. 16, 2021	Mar. 31, 2022	Jul. 31, 2021	Mar. 31, 2022	Apr. 05, 2022	Apr. 06, 2021	Apr. 05, 2021	Mar. 31, 2021	Mar. 05, 2020	Mar. 04, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized			1,500,000,000		1,500,000,000				1,500,000,000	100,000,000	75,000,000
Common Stock, Par or Stated Value Per Share			$ 0.001		$ 0.001				$ 0.001
Fair Value Adjustment of Warrants	$ 513,827
Proceeds from Issuance of Common Stock			$ 287,500		$ 100,000
Sale of Stock, Number of Shares Issued in Transaction			1,742,425
Sale of Stock, Price Per Share			$ 0.16		$ 0.16
Preferred Stock, Shares Authorized			150,000,000		150,000,000				150,000,000
Preferred Stock, Shares Issued			0		0				0
Preferred Stock, Shares Outstanding			0		0				0
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair Value Adjustment of Warrants		$ 53,833
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of convertible securities, shares					4,626,339
Shares, Issued				454,545
Shares Issued, Price Per Share				$ 0.22
Proceeds from Issuance of Common Stock			$ 125,000	$ 100,000
Sale of Stock, Number of Shares Issued in Transaction			757,575
Sale of Stock, Price Per Share			$ 0.17		$ 0.17
Preferred Stock, Shares Authorized							150,000,000	10,000,000
Preferred Stock, Shares Issued			0		0
Preferred Stock, Shares Outstanding						0
Notes Payable [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt Conversion, Converted Instrument, Amount					$ 824,383
Debt Conversion, Converted Instrument, Shares Issued					4,626,339
Addtional debt amount					$ 150,867
Additional debt, shares					1,257,225
Conversion of convertible securities, shares					1,600,000
Notes Payable [Member] | Consulting Fees [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of convertible securities, shares					1,314,827
Notes Payable [Member] | Stock payable [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt Conversion, Converted Instrument, Amount					$ 150,867
Debt Conversion, Converted Instrument, Shares Issued					215,000
Addtional debt amount					$ 64,500
Additional debt, shares					50,000
Payments of Financing Costs					$ 15,000
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right			166,667		166,667
Warrant exercise price			$ 0.30		$ 0.30

SUMMARY OF SIGNIFICANT DEFERRED

SUMMARY OF SIGNIFICANT DEFERRED INCOME TAX ASSETS AND LIABILITIES (Details) - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Deferred income tax assets:
Net operating loss carryforwards
Other
Total deferred income tax assets
Valuation allowance for deferred income tax assets
Net deferred income tax assets

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	May 11, 2022	Mar. 31, 2022
1800 Diagonal Lending LLC [Member]
Subsequent Event [Line Items]
Debt amount		$ 70,000
Debt maturity date		Nov. 15, 2023
GS Capital Partners LLC [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Debt amount	$ 55,000
Debt maturity date	May 17, 2023